Why CERo Therapeutics Stock Is Soaring
Why CERo Therapeutics Stock Is Soaring
CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are racing higher Thursday after the company announced the publication of preclinical research on the use of its clinical candidate CER-1236 to treat AML patients.
週四，CerO Therapeutics Holdings, Inc.（納斯達克股票代碼：CERO）股價飆升，此前該公司宣佈發佈有關使用其臨床候選物 CER-1236 治療急性髓細胞白血病患者的臨床前研究。
The Details:
細節：
The preclinical research found that the target for CER-1236 is found in 83% of leukemic cells extracted from the bone marrow from patients, and CER-1236 effectively eliminated leukemic cells in the company's experiments.
臨床前研究發現，從患者骨髓中提取的 83% 的白血病細胞中發現了 CER-1236 的靶標，在公司的實驗中，CER-1236 有效地消滅了白血病細胞。
"This new publication provides support for our plans to test CER-1236 in AML patients in our planned Phase I clinical trial, and moreover extends the scientific data we have produced showing the target for CER-1236 is present on tumor cells from diverse cancers, including ovarian, non-small cell lung cancer (NSCLC), and B cell malignancies," said Daniel Corey M.D, Ph.D, CERo's CTO.
CeRo首席技術官丹尼爾·科裏醫學博士說：“這份新出版物爲我們在計劃中的I期臨床試驗中對急性髓細胞白血病患者進行CER-1236 測試的計劃提供了支持，此外還擴展了我們生成的科學數據，這些數據表明 CER-1236 的靶點存在於來自不同癌症，包括卵巢癌、非小細胞肺癌（NSCLC）和B細胞惡性腫瘤。”
Related News: Palantir Is Trending On WallStreetBets: Here's What Retail Is Saying On Reddit
相關新聞： Palantir 在 WallstreetBets 上很流行：以下是零售業在 Reddit 上所說的話
By now you're likely curious about how to participate in the market for CERo Therapeutics Hldgs (NASDAQ:CERO) – be it to purchase shares, or even attempt to bet against the company.
到目前爲止，你可能對如何參與CerO Therapeutics Hldgs（納斯達克股票代碼：CERO）的市場感到好奇——無論是購買股票，還是試圖對該公司下注。
How To Buy CERO Stock:
如何購買 CERO 股票：
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
購買股票通常通過經紀賬戶完成。您可以在此處找到可能的交易平台列表。許多股票允許您購買 “部分股票”，這使您無需購買整股即可擁有部分股票。例如，某些股票，例如伯克希爾·哈撒韋公司或亞馬遜，僅擁有一股股票可能要花費數千美元。但是，如果您只想投資其中的一小部分，經紀公司將允許您這樣做。
In the the case of CERo Therapeutics (NASDAQ:CERO), which is trading at $6.34 as of publishing time, $100 would buy you 15.15 shares of stock.
就截至發佈時交易價格爲6.34美元的CerO Therapeutics（納斯達克股票代碼：CERO）而言，100美元將爲你購買15.15股股票。
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
如果你想對一家公司下注，這個過程會更加複雜。您需要訪問期權交易平台或經紀商，該經紀人將允許您 “空頭” 一股股票，將股票借給您。可以在此資源中找到做空股票的過程。否則，如果您的經紀人允許您交易期權，您可以買入看跌期權，也可以以高於當前股票交易價格的行使價賣出看漲期權——無論哪種方式，它都允許您從股價下跌中獲利。
CERO Price Action: According to Benzinga Pro, CERo Therapeutics shares are up 102% at $5.16 at the time of publication.
CERO價格走勢：根據Benzinga Pro的數據，CerO Therapeutics的股價在發佈時上漲了102％，至5.16美元。
Image: Pete Linforth from Pixabay
圖片：來自 Pixabay 的 Pete Linforth